Buy CARBOPLATIN INJECTION BP 10 MG CARBOPLATIN

Carboplatin Injection BP 10 mg is a chemotherapy medication used to treat various types of cancer. This intravenous solution is manufactured by Accord Healthcare Inc. in Canada.

Strength

10 MG

Manufacturer / TM Owner

ACCORD HEALTHCARE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Carboplatin Injection BP 10 mg is primarily used in cancer treatment, often as part of a combination chemotherapy regimen. It works by interfering with the growth and spread of cancer cells. The specific uses of carboplatin may vary depending on the type and stage of cancer, and should be determined by a healthcare professional.

Side Effects

Common effects of carboplatin may include nausea, vomiting, fatigue, and a decrease in blood cell counts. These effects can vary in severity and duration among individuals. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Carboplatin should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant women and individuals with certain medical conditions should exercise caution and consult their doctor before use.

Avoid Interactions

Carboplatin may interact with other medications, including certain chemotherapy drugs and radiation therapy. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of carboplatin.

References

Frequently Asked Questions

Carboplatin is used in the treatment of various types of cancer, often as part of a combination chemotherapy regimen.

Carboplatin is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, and a decrease in blood cell counts.

Pregnant women should consult their healthcare provider before using carboplatin, as it may have potential risks.

If you experience severe or persistent side effects, it is important to contact your healthcare provider immediately.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.